Mycobacterium gordonae: a treatable disease in HIV-positive patients.
Chest
; 104(6): 1779-85, 1993 Dec.
Article
en En
| MEDLINE
| ID: mdl-8252963
ABSTRACT
PURPOSE:
To evaluate the pathogenicity of Mycobacterium gordonae in patients with and without human immunodeficiency virus (HIV) infection. PATIENTS ANDMETHODS:
Twenty-one HIV-positive and 15 HIV-negative patients in a tertiary care center. A descriptive, case-control, and cohort study with a review of the literature with a computer-based data research.RESULTS:
The 15 HIV-negative patients had colonization only. Seven HIV-positive patients had colonization, 12 had possible disease, and 2 had dissemination. The two patients with definitive dissemination improved objectively with treatment.CONCLUSION:
Mycobacterium gordonae in HIV-negative patients is rarely a pathogen. In HIV-positive patients with a low CD4+ cell count, it can cause significant disease and treatment is beneficial.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Tuberculosis Pulmonar
/
Seropositividad para VIH
/
Infecciones Oportunistas Relacionadas con el SIDA
/
Infecciones por Mycobacterium no Tuberculosas
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Chest
Año:
1993
Tipo del documento:
Article